ストックスクリーナーアプリを入手
147.86
0.85%
-1.27
アフターアワーズ：
147.90
0.04
+0.03%
Biogen Inc (BIIB) 最新ニュース
Analyzing Biogen Inc. with multi timeframe charts2025 Top Gainers & Daily Volume Surge Signals - newser.com
Biogen (BIIB): Reassessing Valuation After Recent Share Price Momentum - simplywall.st
United States Biotechnology Market 2025: Industry - openPR.com
Why Biogen Inc. (IDP) stock stays on top picksWeekly Investment Summary & Safe Capital Growth Tips - newser.com
PEGylated Proteins Market See Incredible Growth 2025-2032 | Biogen Inc, Pfizer Inc, and UCB S.A. - openPR.com
Is Biogen Inc. stock a safe buy before earnings2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
United States Biosimilars Market is expected to reach US$ 171.79 - openPR.com
Nisa Investment Advisors LLC Has $6.39 Million Stock Position in Biogen Inc. $BIIB - MarketBeat
Brighton Jones LLC Purchases New Stake in Biogen Inc. $BIIB - MarketBeat
Is Biogen Inc. stock a top momentum playJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect - The Globe and Mail
Biogen Seeks To Stand Out in Lupus With New Anti-CD40L Data - BioSpace
Will Biogen Inc. (IDP) stock benefit from commodity supercycleJuly 2025 Price Swings & Capital Efficiency Focused Strategies - newser.com
Volatility clustering patterns for Biogen Inc.Earnings Risk Summary & Fast Entry High Yield Tips - newser.com
Will Biogen Inc. (IDP) stock benefit from sector leadershipJuly 2025 Selloffs & Safe Capital Growth Tips - newser.com
Sumitomo Mitsui Trust Group Inc. Decreases Stake in Biogen Inc. $BIIB - MarketBeat
Key metrics from Biogen Inc.’s quarterly dataPortfolio Risk Summary & Technical Pattern Alert System - newser.com
Biogen Inc.’s volatility index tracking explainedMarket Performance Report & Verified Short-Term Plans - newser.com
Historical volatility pattern of Biogen Inc. visualizedLong Setup & Weekly Top Gainers Alerts - newser.com
United States Inflammatory Bowel Disease Market is expected - openPR.com
Will Biogen Inc. stock gain from strong economyJuly 2025 Earnings & Fast Gaining Stock Reports - Fundação Cultural do Pará
Institutional scanner results for Biogen Inc.July 2025 Rallies & Technical Analysis for Trade Confirmation - newser.com
Is Biogen Inc. (IDP) stock a buy on weaknessJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
How to escape a deep drawdown in Biogen Inc.Weekly Loss Report & Daily Chart Pattern Signal Reports - newser.com
Biogen’s Felzartamab Trial: A New Hope for Kidney Transplant Patients - TipRanks
Biogen’s PMN Study: A Potential Game-Changer for Kidney Disease Treatment? - TipRanks
Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment? - TipRanks
Biogen’s Litifilimab Study: A Promising Step for Lupus Treatment - TipRanks
Biogen’s New Study on Felzartamab: A Potential Game-Changer for Kidney Transplant Patients - TipRanks
Biogen’s Study on Diroximel Fumarate: A Closer Look at Pregnancy Outcomes - TipRanks
Biogen’s Felzartamab Study: A Potential Game-Changer for IgA Nephropathy - TipRanks
Biogen’s Litifilimab Study: A Potential Game-Changer in Lupus Treatment? - TipRanks
Biogen’s Nusinersen Study: Exploring Pregnancy Outcomes in SMA Patients - TipRanks
Biogen’s Innovative Approach in SMA Treatment: ThecaFlex DRx™ System Study Update - TipRanks
Biogen’s Innovative Approach to SMA Treatment: A Study Update - TipRanks
Biogen’s New Study on Omaveloxolone: A Potential Game-Changer for Friedreich’s Ataxia - TipRanks
Biogen’s BIIB142 Study: A New Chapter in Drug Safety Evaluation - TipRanks
Biogen and Denali’s New Study on LRRK2-Associated Parkinson’s Disease: What Investors Need to Know - TipRanks
Biogen’s Innovative Study on Litifilimab Delivery: Market Implications and Study Insights - TipRanks
Biogen, Inc. Experiences Valuation Adjustment Amidst Market Performance Challenges - Markets Mojo
Biogen’s Pregnancy Exposure Study: Implications for MS Treatment Market - TipRanks
Biogen’s Zuranolone Study: A Potential Game-Changer for Postpartum Depression Treatment - TipRanks
Biogen’s Omaveloxolone Study: Assessing Safety During Pregnancy and Lactation - TipRanks
Biogen’s New MS Study: A Potential Game-Changer for Investors? - TipRanks
Biogen’s Omaveloxolone Study: A Closer Look at Long-Term Safety for Friedreich’s Ataxia - TipRanks
Biogen Still Has Competitive Advantages in Neurology, but Its Moat Looks Narrow - Morningstar
Health Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer’s Disease - Cantech Letter
Health Canada Grants Authorization for LEQEMBI® (lecanemab) for the Treatment of Early Alzheimer's Disease - Newswire Canada
AustralianSuper Pty Ltd Has $92.86 Million Stake in Biogen Inc. $BIIB - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Cuts Stock Position in Biogen Inc. $BIIB - MarketBeat
Using portfolio simulators with Biogen Inc. includedMarket Performance Report & Free Safe Entry Trade Signal Reports - newser.com
How Biogen Inc. (IDP) stock behaves in tightening cycles2025 Market Sentiment & Risk Managed Trade Strategies - newser.com
Sector ETF performance correlation with Biogen Inc.Quarterly Investment Review & Entry and Exit Point Strategies - newser.com
0.74%
0.53%
大文字化:
|
ボリューム (24 時間):